TBF1.F - Canntab Therapeutics Limited

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2019-05-31
2018-05-31
2017-12-31
2017-05-31
2016-12-31
Cash flows from operating activities
Net Income
-2,452
-2,459
-2,408
-182
-1,116
520
Depreciation & amortization
115
81
51
-
2
-
Stock based compensation
400
402
320
0
682
51
Change in working capital
-49
-317
108
73
78
-128
Accounts receivable
-93
-70
-129
-0
20
-8
Other working capital
-2,884
-2,651
-1,468
-115
-454
-409
Other non-cash items
-
-40
660
-
-
51
Net cash provided by operating activites
-2,159
-2,333
-1,269
-115
-355
-409
Cash flows from investing activities
Investments in property, plant and equipment
-725
-318
-199
-
-100
-
Other investing activites
-
-
-
-
-
0
Net cash used for investing activites
2,600
2,007
-199
0
-100
1,166
Cash flows from financing activities
Common stock issued
-
0
5,008
100
1,413
-
Other financing activites
-
-
-481
-
-
-852
Net cash used privided by (used for) financing activities
-
22
4,727
100
1,413
-852
Net change in cash
-
-
-
-15
959
-95
Cash at beginning of period
3,496
718
959
16
0
111
Cash at end of period
3,938
414
4,218
1
959
16
Free Cash Flow
Operating Cash Flow
-2,159
-2,333
-1,269
-115
-355
-409
Capital Expenditure
-725
-318
-199
-
-100
-
Free Cash Flow
-2,884
-2,651
-1,468
-115
-454
-409